drugset / Trial / NCT04315103

a Single HYAJOINT Plus Combined With a Single PPR Versus a Single PRP for Knee OA

NCT04315103 ↗

Phase 2 Completed 85 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupSingle-blindTreatment

Summary

Intraarticular hyaluronan or platelet-rich plasma (PRP) is each effective in the treatment for knee osteoarthritis (OA). The efficacy of combined hyaluronan with PRP for knee OA remained unclear. This study aimed to investigate the efficacy of a single intraarticular hyaluronan (HYAJOINT Plus) combined with a single PRP versus a single intraarticular PRP in patients with knee OA.

Timeline

Start
2018-08-01
Primary completion
2019-01-10
Completion
2019-07-10

Outcome

Met primary endpoint

paper However, at 6-month follow-up, the combined-injection group achieved significantly better VAS pain reduction (p = 0.020). PMID 33420185 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronan Other / unclassified 3 ml Other
Subject Platelet Rich Plasma Other / unclassified 3 ml Other

Indications